Zacks Investment Research on MSN1d
AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer IndicationAstraZeneca AZN announced that the FDA has approved its blockbuster drug, Imfinzi (durvalumab), for a bladder cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback